About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lymphoma Clinical Trials in Washington | 859 Studies

Clinical Trials LymphomaWashington

Lymphoma Clinical Trials in Washington

Find 859 clinical trials for lymphoma near Washington. Connect with research centers in your area.

All Lymphoma trials nationwide All trials in Washington

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 381-400 of 859 trials

CompletedSevere Asthma Research ProgramThe mission of the SARP is to improve the understanding of severe asthma through integrated study of its clinical and biological features and to evaluate their changes over time.NCT01606826·San Francisco, California and 7 others TerminatedTAK-659 in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)The purpose of this study is to assess the efficacy of TAK-659 measured by independent radiologic review committee (IRC)-assessed overall response rate (ORR) in participants with…NCT03123393·Westwood, Kansas and 40 others

Lymphoma Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

Active not recruitingA Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab in Combination With Oral and Intravenous Anti-Neoplastic Agents in Adult Participants With Non-Hodgkin LymphomaB-cell Lymphoma is an aggressive and rare cancer of a type of immune cell (a white blood cell responsible for fighting infections).NCT05283720·Tucson, Arizona and 75 others

TerminatedAcceleration of Platelet Recovery Following Autologous Peripheral Blood Stem Cell Transplant (PBSC) in Hodgkin, Non-Hodgkin Lymphoma or Multiple Myeloma PatientsThe purpose of this study is to determine the safety and effectiveness of TXA127 in accelerating the time it takes for patients to recover their platelet counts following a…NCT01121120·Duarte, California and 9 others

CompletedStudy of Ibrutinib Combined With Venetoclax in Subjects With Mantle Cell Lymphoma (MCL)This Phase 3 multinational, randomized, double-blind study is designed to compare the efficacy and safety of the combination of ibrutinib and venetoclax vs. ibrutinib and placebo…NCT03112174·Tucson, Arizona and 119 others

CompletedTraumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell TransplantationRATIONALE: Traumeel® S (a mouth rinse) may be effective in preventing or decreasing the severity of oral mucositis caused by chemotherapy in young patients who are undergoing stem…NCT00080873·Birmingham, Alabama and 43 others

Enrolling by invitationLong-Term Follow-up StudyThis is an observational, non-interventional, LTFS of investigational Caribou therapies in patients who have participated in a parent study: a prior Caribou-sponsored clinical…NCT05332054·Birmingham, Alabama and 30 others

Active not recruitingA Phase I/II Study to Evaluate the Safety of Cellular Immunotherapy Using Autologous T Cells Engineered to Express a CD20-Specific Chimeric Antigen Receptor for Patients With Relapsed or Refractory B Cell Non-Hodgkin LymphomasThe purpose of this research is to find the best dose of genetically modified T-cells, to study the safety of this treatment, and to see how well it works in treating patients…NCT03277729·Seattle, Washington

WithdrawnHIV-Resistant Gene Modified Stem Cells and Chemotherapy in Treating Patients With Lymphoma With HIV InfectionThis pilot phase I trial studies the side effects and best dose of human immunodeficiency virus (HIV)-resistant gene modified stem cells in treating HIV-positive patients who are…NCT02343666·Seattle, Washington

CompletedBendamustine and Rituximab Alternating With Cytarabine and Rituximab for Untreated Mantle Cell LymphomaGiven the established role of high dose cytarabine (HiDAC) combined with rituximab, along with recent data showing the encouraging efficacy of bendamustine, the investigators seek…NCT02728531·St Louis, Missouri

CompletedSafety and Efficacy of POL6326 for Mobilization/Transplant of Sibling Donor in Patients With Hematologic MalignanciesDetermine the safety and tolerability of POL6326 when used as a single mobilization agent.NCT01413568·Kansas City, Kansas and 1 other

Active not recruitingStudy of Oral MRT-2359 in Selected Cancer PatientsThis Phase 1/2, open-label, multicenter study is conducted in patients with previously treated selected solid tumors, including non-small cell lung cancer (NSCLC), small cell lung…NCT05546268·Scottsdale, Arizona and 16 others

CompletedEfficacy and Safety Study of Lenalidomide Plus R-CHOP Chemotherapy Versus Placebo Plus R-CHOP Chemotherapy in Untreated ABC Type Diffuse Large B-cell LymphomaTo evaluate the efficacy and safety of lenalidomide, rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R2-CHOP) chemotherapy versus placebo, rituximab…NCT02285062·Fayetteville, Arkansas and 157 others

CompletedZanubrutinib (BGB-3111) in Participants With Previously Treated B-Cell Lymphoma Intolerant of Prior Bruton Tyrosine Kinase Inhibitor (BTKi) TreatmentThe primary objective of this study is to evaluate the safety of zanubrutinib (also known as BGB-3111) in chronic lymphocytic leukemia/small lymphocytic lymphoma, Waldenström…NCT04116437·Aurora, Colorado and 23 others

CompletedAlemtuzumab, Fludarabine Phosphate, and Low-Dose Total Body Irradiation Before Donor Stem Cell Transplantation in Treating Patients With Hematological MalignanciesThis phase II trial studies the side effects and the best dose of alemtuzumab when given together with fludarabine phosphate and low-dose total body irradiation (TBI) and how well…NCT00040846·Denver, Colorado and 6 others

RecruitingA Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular LymphomaThe purpose of this study is to find out if mosunetuzumab is an effective treatment in people with follicular lymphoma that was recently diagnosed and have not yet received any…NCT05389293·Washington D.C., District of Columbia and 8 others

RecruitingEfficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)The purpose of this study is to evaluate the safety and efficacy of nemtabrutinib (formerly ARQ 531) in participants with hematologic malignancies of chronic lymphocytic leukemia…NCT04728893·Springdale, Arkansas and 120 others

Active not recruitingA Study of TAK-007 in Adults With Relapsed or Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)This study has 2 parts.NCT05020015·Birmingham, Alabama and 14 others

CompletedPhase II Study of Bendamustine and Rituximab Plus Venetoclax in Untreated Mantle Cell Lymphoma Over 60 Years of AgeEligible untreated patients will receive single arm venetoclax, bendamustine and rituximab as induction therapy.NCT03834688·Urbana, Illinois and 6 others

CompletedPhase II Study of Dose-Adjusted EPOCH-Rituximab in Adults With Untreated Burkitt Lymphoma and c-MYC+ Diffuse Large B-Cell LymphomaBackground: * Burkitt lymphoma/leukemia (BL) is highly treatable, but most of the standard therapies require multiple doses of intensive chemotherapy that may require long…NCT01092182·La Jolla, California and 29 others

PreviousPage 20 of 43Next

Other Conditions in Washington

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia